Observations on Treatment with Ibogaine
Clinical protocols Case series moderate
AI-extracted · unverified · confirm at source
Ibogaine 20-25 mg/kg caused transient vestibulocerebellar dysfunction (nystagmus, intention tremor, ataxia) resolving by 24h; no ECG or EEG abnormalities; no withdrawal/craving at 24h
Dosing: 1 mg/kg test dose (day 1); 20–25 mg/kg ibogaine HCl full dose (day 2) (oral)
Sample size: 3